A look at OpenAI-backed Red Queen Bio, an AI biosecurity startup with $36M raised to design antibody drugs against pathogens, including AI-enabled bioweapons (Georgia Wells/Wall Street Journal)
Red Queen Bio is trying to pre-build antibody defenses for pathogens that may not exist yet.
The OpenAI-backed startup has raised $36 million, according to Techmeme’s summary of the Wall Street Journal story. Its work centers on using AI to design antibody drugs against novel pathogens, including ones that could be enabled by AI bioweapons. The premise is speed: develop defenses before future AI systems make new threats possible. Techmeme's note
The OpenAI-backed startup has raised $36 million, according to Techmeme’s summary of the Wall Street Journal story. Its work centers on using AI to design antibody drugs against novel pathogens, including ones that could be enabled by AI bioweapons. The premise is speed: develop defenses before future AI systems make new threats possible. Techmeme's note
score 6